fluorescein-5-isothiocyanate has been researched along with gambogic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Chen, Z; Ke, WJ; Wang, Y; Wu, Q; Wu, QL | 1 |
| Jin, C; Kitada, S; Reed, JC; Satterthwait, AC; Shiau, CW; Zhai, D | 1 |
2 other study(ies) available for fluorescein-5-isothiocyanate and gambogic acid
| Article | Year |
|---|---|
Gambogic acid induces death inducer-obliterator 1-mediated apoptosis in Jurkat T cells.
Topics: Annexin A5; Apoptosis; Bisbenzimidazole; Caspase 3; Cell Nucleus; Cell Proliferation; Cell Survival; DNA Fragmentation; DNA-Binding Proteins; Dose-Response Relationship, Drug; Down-Regulation; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Formazans; Humans; Inhibitory Concentration 50; Jurkat Cells; Molecular Structure; NF-kappa B; Propidium; Proto-Oncogene Proteins c-bcl-2; T-Lymphocytes; Tetrazolium Salts; Xanthones | 2008 |
Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; BH3 Interacting Domain Death Agonist Protein; Binding Sites; Binding, Competitive; Cell Line, Tumor; Cytoprotection; Drug Screening Assays, Antitumor; Fluorescein-5-isothiocyanate; Fluorescence Resonance Energy Transfer; Humans; Mice; Minor Histocompatibility Antigens; Mitochondria; Peptides; Proto-Oncogene Proteins c-bcl-2; Time Factors; Xanthones | 2008 |